SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-19-001231
Filing Date
2019-03-11
Accepted
2019-03-11 17:03:46
Documents
81
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F form20f.htm 20-F 1276962
2 EXHIBIT 4.1 exhibit4-1.htm EX-4.1 149533
3 EXHIBIT 4.5 exhibit4-5.htm EX-4.5 37018
4 EXHIBIT 12.1 exhibit12-1.htm EX-12.1 8343
5 EXHIBIT 12.2 exhibit12-2.htm EX-12.2 8340
6 EXHIBIT 13.1 exhibit13-1.htm EX-13.1 3203
7 EXHIBIT 13.2 exhibit13-2.htm EX-13.2 3148
8 EXHIBIT 15.1 exhibit15-1.htm EX-15.1 1496
9 EXHIBIT 16.1 exhibit16-1.htm EX-16.1 56113
10 GRAPHIC form20fx28x1.jpg GRAPHIC 23957
11 GRAPHIC form20fx30x1.jpg GRAPHIC 33708
12 GRAPHIC trilogo.jpg GRAPHIC 6207
  Complete submission text file 0001062993-19-001231.txt   4945916

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE tril-20181231.xml EX-101.INS 677533
14 XBRL CALCULATION FILE tril-20181231_cal.xml EX-101.CAL 34204
15 XBRL DEFINITION FILE tril-20181231_def.xml EX-101.DEF 299091
16 XBRL LABEL FILE tril-20181231_lab.xml EX-101.LAB 361379
17 XBRL PRESENTATION FILE tril-20181231_pre.xml EX-101.PRE 332056
18 XBRL SCHEMA FILE tril-20181231.xsd EX-101.SCH 69521
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: 20-F | Act: 34 | File No.: 001-36596 | Film No.: 19672988
SIC: 2834 Pharmaceutical Preparations